Suggestions
Tvrtko Kujundzic
Sr. Director, BinaxNOW COVID-19 & NAVICA, Abbott Rapid Diagnostics at Abbott
Tvrtko Kujundzic is a seasoned healthcare and consumer products executive with extensive experience in global strategy and North American P&L roles.2 He currently holds a leadership position at Abbott Rapid Diagnostics, a division of Abbott, a major healthcare and pharmaceuticals company based in Illinois, United States.12
Current Role
While the query mentions Tvrtko Kujundzic as Sr. Director, BinaxNOW COVID-19, more recent information suggests he has progressed to higher positions within Abbott Rapid Diagnostics:
- Division Vice President, Infectious Diseases Marketing - Abbott Rapid Diagnostics34
- General Manager, Consumer Wellness - Abbott Rapid Diagnostics3
These roles indicate his involvement in key areas of Abbott's diagnostic business, particularly in infectious diseases and consumer wellness products.
Professional Background
Tvrtko Kujundzic has over 17 years of experience in the healthcare technology and consumer products industries. His career at Abbott has involved various leadership roles, showcasing his expertise in:
- Global strategy
- North American P&L management
- Marketing and product management
- Consumer wellness and infectious diseases diagnostics
Location and Contact
Tvrtko Kujundzic is based in the Greater Chicago Area.45 While specific contact information is not provided for privacy reasons, he can be reached through professional networks or Abbott's corporate channels.
Abbott and Rapid Diagnostics
Abbott is a global healthcare company specializing in nutrition, diagnostics, medical devices, and branded generic pharmaceuticals.1 The Rapid Diagnostics division, where Tvrtko works, focuses on developing and marketing diagnostic tests, including those for infectious diseases like COVID-19.
Tvrtko Kujundzic's role in this division, particularly his involvement with products like BinaxNOW COVID-19, highlights his contribution to Abbott's efforts in addressing global health challenges through innovative diagnostic solutions.